No registrations found.
ID
Source
Brief title
Intervention
Outcome measures
Primary outcome
PASI and SAPASI-scores.
Secondary outcome
Quality of Life (SF-36, EQ-5D, PDI) and Cost-effectiveness.
Background summary
N/A
Study objective
N/A
Study design
N/A
Intervention
Randomisation in two treatment groups:
home UVB phototherapy or UVB phototherapy in the hospital (both therapies are common practice in the Netherlands).
P.O. Box 85500
Mayke B.G. Koek
Utrecht 3508 GA
The Netherlands
+31 (0)30 2507388
M.B.G.Koek@azu.nl
P.O. Box 85500
Mayke B.G. Koek
Utrecht 3508 GA
The Netherlands
+31 (0)30 2507388
M.B.G.Koek@azu.nl
Inclusion criteria
1. Psoriasis patients: plaque or guttata psoriasis;
2. Eligible for total-body home UVB phototherapy based on the severity of the psoriatic skin lesions;
3. Willing AND capable to participate in both possible treatment arms (treatment at home and in the hospital);
4. Sufficient knowledge of the dutch language;
5. Age 18 years or more;
6. Does have a telephone.
Exclusion criteria
1. Analphabetism;
2. Expected non-compliance;
3. History of malignicy of the skin;
4. Known UVB allergy;
5. Chronic Polymorfic Light Eruption (CPLE);
6. Use of (systemic) medication with known phototoxic or photo-allergic properties;
7. Use of the following systemic medication: Ciclosporin (neoral), Methotrexate, acitretin (neotigason);
8. History of ionising radiation.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6 |
| NTR-old | NTR30 |
| Other | : N/A |
| ISRCTN | ISRCTN83025173 |